Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    21217520 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Safety and Efficacy of Combination Listeria/GVAX Pancreas Vaccine in the Pancreatic Cancer Setting
Condition: 2nd-line, 3rd-line and Greater Metastatic Pancreatic Cancer
Interventions: Biological: GVAX Pancreas Vaccine;   Biological: CRS-207;   Drug: gemcitabine, capecitabine, 5-FU, irinotecan or erlotinib;   Drug: cyclophosphamide
2 Completed
Has Results
Vaccine Therapy Combined With Adjuvant Chemoradiotherapy in Treating Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas
Condition: Pancreatic Cancer
Intervention: Biological: GVAX pancreatic cancer vaccine

Indicates status has not been verified in more than two years